Enanta Pharmaceuticals Inc’s recently made public that its Director Vance Terry unloaded Company’s shares for reported $0.14 million on Dec 13 ’23. In the deal valued at $9.12 per share,15,295 shares were sold. As a result of this transaction, Vance Terry now holds 5,800 shares worth roughly $89088.0.
Then, Luly Jay R. sold 7,230 shares, generating $69,625 in total proceeds. Upon selling the shares at $9.63, the President and CEO now owns 806,793 shares.
Before that, MELLETT PAUL J sold 2,412 shares. Enanta Pharmaceuticals Inc shares valued at $23,228 were divested by the Sr. VP, Finance & Admin. & CFO at a price of $9.63 per share. As a result of the transaction, MELLETT PAUL J now holds 93,549 shares, worth roughly $1.44 million.
JP Morgan downgraded its Enanta Pharmaceuticals Inc [ENTA] rating to an Underweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in early August from “a Buy” to “a Hold”. H.C. Wainwright began covering ENTA with “Buy” recommendation on December 09, 2022. Evercore ISI revised its rating on July 06, 2022. It rated ENTA as “an Outperform” which previously was an “an In-line”.
Price Performance Review of ENTA
On Tuesday, Enanta Pharmaceuticals Inc [NASDAQ:ENTA] saw its stock fall -4.89% to $15.36. Over the last five days, the stock has lost -8.68%. Enanta Pharmaceuticals Inc shares have risen nearly 63.23% since the year began. Nevertheless, the stocks have fallen -57.95% over the past one year. While a 52-week high of $38.79 was reached on 04/01/24, a 52-week low of $8.08 was recorded on 01/02/24. SMA at 50 days reached $14.64, while 200 days put it at $13.14. A total of 0.21 million shares were traded, compared to the trading of 0.16 million shares in the previous session.
Levels Of Support And Resistance For ENTA Stock
The 24-hour chart illustrates a support level at 15.08, which if violated will result in even more drops to 14.81. On the upside, there is a resistance level at 15.88. A further resistance level may holdings at 16.41. The Relative Strength Index (RSI) on the 14-day chart is 47.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.79%. Stochastics %K at 40.41% indicates the stock is a holding.
